Chinese herbal medicine for treating hemopathy

Abstract

The invention relates to a Chinese herbal medicine for treating various types of aplastic anemia, anemia, thrombocytopenia, myeloproliferative pancytopenia, leukemia and other blood diseases. Its formula is: decoction raw materials: angelica 12-18g, astragalus 12-18g, peony 12-18g, yam 9-15g, sealwort 14-26g, licorice 7-13g, Atractylodes macrocephala 12-18g, honeysuckle vine 14-26g , Daqing root 14-26g, Ascaria japonica 24-36g, Jupiter root 24-36g, Litchi grass 12-18g, Dandelion 12-18g; powder raw materials: Japanese water bayberry 0.7-1.3g, stone toad 0.2-0.4 g, panax notoginseng 0.1-0.3g, cucumber root 0.3-0.7g, philodendron 1.2-1.8g, trifoliate green 0.3-0.7g; the formula of the invention is reasonable, and has the effects of strengthening the body and eliminating pathogens, benefiting yin and yang, and invigorating the blood. It can improve the phagocytosis of macrophages, reduce the damage of bone marrow microcirculation, inhibit the growth of pathological cells, enhance the immunity of the body, and have stable curative effect. Clinical experiments prove that the total effective rate of the curative effect of the present invention is about 98%, and the cure rate is above 90%.

Description

Technical field [0001] The invention relates to a Chinese herbal medicine for treating various types of aplastic anemia, anemia, thrombocytopenia, myeloproliferative pancytopenia, leukemia and other blood diseases. Background technique [0002] Leukemia, commonly known as "blood cancer", is a malignant disease of the hematopoietic system that endangers people's health, especially adolescents and children. Most leukemia patients generally use western medicine chemotherapy. Although this therapy can kill a large number of proliferating immature cells, it lacks the necessary safety and effectiveness. Because chemotherapy drugs kill proliferating immature cells, it also kills many normal cells and white blood cells, which reduces the patient’s immune system, which may cause early infections and other complications. The failure of chemotherapy is mainly due to infection during chemotherapy. Hemorrhage causes early death, or leukemia cells are resistant to drug resistance and have no e...

AI Technical Summary

Problems solved by technology

After consulting, the Chinese patent document application number 92103647.7 discloses "a preparation method of traditional Chinese medicine for treating leukemia". Ben Peiyuan, regulates qi and blood, alleviates the disease, and prolongs the survival period of leukemia patients. However, this composition is mainly suitable for leukemia and has auxiliary effects on aplastic anemia. There are no reports that it can also treat other blood diseases. efficacy is not high enough